
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Bretylium &amp; Guanethidine: Two New Drugs Producing Specific Blockade of the Sympathetic Nervous System</dc:title>
  <dc:subject>Hypertension</dc:subject>
  <dc:subject>Antihypertensive Agents</dc:subject>
  <dc:subject>Guanethidine</dc:subject>
  <dc:subject>Bretylium Compounds</dc:subject>
  <dc:description>In this brief article, intended to acquaint practicing physicians with several new ganglionic blocking agents, Freis provided an overview of how bretylium tosylate and guanethidine acted to treat hypertension, but due to the dearth of clinical testing on these relatively new drugs, did not provide many details as to their effectiveness.</dc:description>
  <dc:publisher>The Medical Arts Publishing Foundation, [September-October 1960]</dc:publisher>
  <dc:contributor>The Heart Bulletin</dc:contributor>
  <dc:contributor>Freis, Edward D.</dc:contributor>
  <dc:type>Articles</dc:type>
  <dc:format>Archival Materials</dc:format>
  <dc:format>Text</dc:format>
  <dc:format>2 pages</dc:format>
  <dc:identifier>nlm:nlmuid-101584929X34-doc</dc:identifier>
  <dc:identifier>101584929X34</dc:identifier>
  <dc:identifier>http://resource.nlm.nih.gov/101584929X34</dc:identifier>
  <dc:identifier>Profiles ID: XFBBCQ</dc:identifier>
  <dc:language>English</dc:language>
  <dc:relation>Profiles in Science</dc:relation>
</oai_dc:dc>